Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Table 2

Comprehensive assessment of COPD participants.

Group	LHQW group; (𝑛=50)	Conventional group; (𝑛=50)	Statistical significance
Low-risk subgroups; (A-B groups)	25	20	NS
High-risk subgroups; (C-D groups)	25	30	NS

NS: nonsignificant difference between the two groups, 𝑃 value ≥0.05.